We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.025 | -0.57% | 4.375 | 4.25 | 4.50 | 4.625 | 4.25 | 4.625 | 2,228,810 | 15:04:32 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -0.98 | 5.03M |
From May 2022 to May 2024
TIDMGDR
RNS Number : 4815I
Genedrive PLC
05 December 2022
genedrive plc
("genedrive" or the "Company")
Annual Report and Accounts and date of AGM
genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that its 2022 Annual Report and Accounts are now available on the Company's website http://www.genedriveplc.com/investor-relations/company-reports.php . The Notice of the 2022 Annual General Meeting ("AGM") and hard copies of the 2022 Annual Report and Accounts will be posted to shareholders on or around 5 December 2022.
The Company's AGM will be held at 11am on 29 December 2022 at 46 Grafton Street, Manchester M13 9XX.
For further details please contact:
Hot Features
Premium
genedrive plc +44 (0)161 989 0245
David Budd: CEO / Russ Shaw: CFO
Peel Hunt LLP (Nominated Adviser
and Joint Broker) +44 (0)20 7418 8900
James Steel / Oliver Duckworth
finnCap (Joint Broker) +44 (0)20 7220 500
Geoff Nash / George Dollemore / Nigel
Birks / Alice Lane
Walbrook PR Ltd (Media Relations +44 (0)20 7933 8780 or genedrive@walbrookpr.com
& Investor Relations)
+44 (0)7980 541 893 / +44 (0)7876
Paul McManus / Anna Dunphy 741 001
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NOABXBDDCDGDGDD
(END) Dow Jones Newswires
December 05, 2022 02:00 ET (07:00 GMT)
1 Year Genedrive Chart |
1 Month Genedrive Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
